Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions

被引：3
|
作者：
Wang, Norman C. [1 ]
Piccini, Jonathan P. [2 ]
Gheorghiade, Mihai [3 ]
机构：
[1] Univ Pittsburgh, Cardiovasc Inst, Med Ctr, Pittsburgh, PA 15213 USA
[2] Duke Clin Res Ctr, Durham, NC USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
HEART FAILURE REVIEWS | 2011年 / 16卷 / 05期
关键词：
Implantable cardioverter-defibrillator; Heart failure; Hospitalization; Mortality; VENTRICULAR EJECTION FRACTION; MYOCARDIAL-INFARCTION; SURVIVAL; HOSPITALIZATION; DEATH;
D O I：
10.1007/s10741-011-9243-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Implantable cardioverter-defibrillators have proven efficacy in reducing mortality in patients with reduced left ventricular ejection fraction in both the primary and the secondary prevention settings. All randomized trials demonstrating this benefit have been conducted in outpatients with stable heart failure symptoms. Whether implantable cardioverter-defibrillators confer a benefit when implemented in patients with chronically reduced left ventricular ejection fraction in the acute heart failure setting is unknown. The purpose of this document is to review the existing literature related to this subject.
引用
收藏
页码：477 / 480
页数：4
相关论文
共 50 条
  • [31] Survival in patients with heart failure and implantable cardioverter-defibrillator in an electrophysiological unit in Pereira, Colombia
    Arango-Franco, Ricardo
    Martinez, Jose-William
    Sosa-Urrea, Juan-David
    Marin-Medina, Daniel-Stiven
    Orozco-Hernandez, Juan-Pablo
    Martinez-Munoz, Manuel-Andres
    Henao-Martinez, Juan-Fernando
    Sanchez-Duque, Jorge-Andres
    ARCHIVOS DE MEDICINA, 2021, 21 (01): : 35 - 44
  • [32] Is Anyone Too Old for an Implantable Cardioverter-Defibrillator?
    Heidenreich, Paul A.
    Tsai, Vivian
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (01): : 6 - 8
  • [33] Implantable cardioverter-defibrillator: Is remote monitoring obligatory?
    Horlbeck F.W.
    Schwab J.O.
    Herzschrittmachertherapie + Elektrophysiologie, 2015, 26 (2) : 116 - 122
  • [34] Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?
    Ambrosy, Andrew P.
    Parzynski, Craig S.
    Friedman, Daniel J.
    Fudim, Marat
    Hernandez, Adrian F.
    Fonarow, Gregg C.
    Masoudi, Frederick A.
    Al-Khatib, Sana M.
    CIRCULATION, 2018, 138 (24) : 2787 - 2797
  • [35] Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management An Analysis in Clinical Practice
    Calo, Leonardo
    Bianchi, Valter
    Ferraioli, Donatella
    Santini, Luca
    Dello Russo, Antonio
    Carriere, Cosimo
    Santobuono, Vincenzo Ezio
    Andreoli, Chiara
    La Greca, Carmelo
    Arena, Giuseppe
    Talarico, Antonello
    Pisano, Ennio
    Santoro, Amato
    Giammaria, Massimo
    Ziacchi, Matteo
    Viscusi, Miguel
    De Ruvo, Ermenegildo
    Campari, Monica
    Valsecchi, Sergio
    D'Onofrio, Antonio
    CIRCULATION-HEART FAILURE, 2021, 14 (10) : 1072 - 1079
  • [36] Predictors of ventricular tachyarrhythmia in patients with implantable cardioverter-defibrillator and non-ischemic systolic heart failure
    Jedrzejczyk-Patej, Ewa
    Mazurek, Michal
    Lazar, Monika
    Pruszkowska-Skrzep, Patrycja
    Sokal, Adam
    Kowalczyk, Jacek
    Kowalski, Oskar
    Kalarus, Zbigniew
    Lenarczyk, Radoslaw
    KARDIOLOGIA POLSKA, 2023, 81 (10) : 998 - 1005
  • [37] Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention
    Khazanie, Prateeti
    Hellkamp, Anne S.
    Fonarow, Gregg C.
    Bhatt, Deepak L.
    Masoudi, Frederick A.
    Anstrom, Kevin J.
    Heidenreich, Paul A.
    Yancy, Clyde W.
    Curtis, Lesley H.
    Hernandez, Adrian F.
    Peterson, Eric D.
    Al-Khatib, Sana M.
    Journal of the American Heart Association, 2015, 4 (08): : e002061
  • [38] Acute Effects of Implantable Cardioverter-Defibrillator Shocks on Biomarkers of Myocardial Injury, Apoptosis, Heart Failure, and Systemic Inflammation
    Brewster, Jordan
    Sexton, Travis
    Dhaliwal, Gary
    Charnigo, Richard
    Morales, Gustavo
    Parrott, Kevin
    Darrat, Yousef
    Gurley, John
    Smyth, Susan
    Elayi, Claude S.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2017, 40 (04): : 344 - 352
  • [39] Novel intravascular defibrillator: Defibrillation thresholds of intravascular cardioverter-defibrillator compared to conventional implantable cardioverter-defibrillator in a canine model
    Sanders, William E., Jr.
    Richey, Mark W.
    Malkin, Robert A.
    Masson, Stephen C.
    Ransbury, T. J.
    Urtz, Mark W.
    Ideker, Raymond E.
    HEART RHYTHM, 2011, 8 (02) : 288 - 292
  • [40] Subcutaneous Implantable Cardioverter-Defibrillator Technology
    Gupta, Anurag
    Al-Ahmad, Amin
    Wang, Paul J.
    HEART FAILURE CLINICS, 2011, 7 (02) : 287 - +
12345